advisorsecurities master

BNTCBenitec Biopharma Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
12730
Ticker
BNTC
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2012-07-11
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
BNTC

Detail

Enriched 2026-08-14 20:47

Market cap
$423,932,481.56
Shares outstanding (class)
34,354,334
Shares outstanding (weighted)
34,354,334
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
19
Location
HAYWARD, CA
Description

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data